PPIs in GORD: supporting patients to step down
Discuss your patients' expectations of gastro-oesophageal reflux disease (GORD) management and assess their ongoing need for Proton-pump inhibitors (PPIs) with the aim of stepping down treatment.
COPD: demonstrating devices, evaluating medicines
Update your knowledge about the stepwise approach to managing chronic obstructive pulmonary disease (COPD), and review the range of medicines and devices currently used to treat COPD.
Type 2 diabetes: a patient-centred approach
Update your knowledge about the range of glucose-lowering medicines available and their role in the treatment of type 2 diabetes.
PPIs: reviewing treatment for gastro-oesophageal reflux disease
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Statins: promoting adherence, addressing intolerance
Optimise your patients’ adherence to lipid-modifying medicines and improve your confidence in assessing suspected statin-associated muscle symptoms.
Rheumatoid arthritis: optimising treatment
How can you optimise a patient’s methotrexate therapy for the management of rheumatoid arthritis?
Rheumatoid arthritis: getting the facts straight about methotrexate
Optimal management of patients with rheumatoid arthritis depends on successful collaboration between rheumatologists, GPs and community pharmacists.
CV risk in patients with type 2 diabetes and CVD: getting to the heart of diabetes
Listen to our multidisciplinary panel of experts as they discuss the prevention of CV events in patients with both type 2 diabetes and CVD.